Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer

In cancer patients, hypercoagulability is a common finding. It has been associated with an increased risk of venous thromboembolism, but also to tumor proliferation and progression. In this prospective study of a large cohort of breast cancer patients, we aimed to evaluate whether pre-chemotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Giaccherini, Cinzia, Marchetti, Marina, Masci, Giovanna, Verzeroli, Cristina, Russo, Laura, Celio, Luigi, Sarmiento, Roberta, Gamba, Sara, Tartari, Carmen J., Diani, Erika, Vignoli, Alfonso, Malighetti, Paolo, Spinelli, Daniele, Tondini, Carlo, Barni, Sandro, Giuliani, Francesco, Petrelli, Fausto, D’Alessio, Andrea, Gasparini, Giampietro, De Braud, Filippo, Santoro, Armando, Labianca, Roberto, Falanga, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271573/
https://www.ncbi.nlm.nih.gov/pubmed/31558668
http://dx.doi.org/10.3324/haematol.2019.228981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271573/
https://www.ncbi.nlm.nih.gov/pubmed/31558668
http://dx.doi.org/10.3324/haematol.2019.228981

Ejemplares similares